Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Twist1-induced invadopodia formation promotes tumor metastasis.

Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, Yang J.

Cancer Cell. 2011 Mar 8;19(3):372-86. doi: 10.1016/j.ccr.2011.01.036.

2.

Transcription factors zeb1, twist and snai1 in breast carcinoma.

Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A, Kosma VM.

BMC Cancer. 2011 Feb 16;11:73. doi: 10.1186/1471-2407-11-73.

3.

A systems view of epithelial-mesenchymal transition signaling states.

Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM, Haley JD.

Clin Exp Metastasis. 2011 Feb;28(2):137-55. doi: 10.1007/s10585-010-9367-3. Epub 2010 Dec 31.

4.

Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6.

Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B, Sahai E.

Nat Cell Biol. 2011 Jan;13(1):49-58. doi: 10.1038/ncb2133. Epub 2010 Dec 19.

5.

Hsp27 protects adenocarcinoma cells from UV-induced apoptosis by Akt and p21-dependent pathways of survival.

Kanagasabai R, Karthikeyan K, Vedam K, Qien W, Zhu Q, Ilangovan G.

Mol Cancer Res. 2010 Oct;8(10):1399-412. doi: 10.1158/1541-7786.MCR-10-0181. Epub 2010 Sep 21.

6.

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.

Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, Mani SA.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54. doi: 10.1073/pnas.1004900107. Epub 2010 Aug 16. Erratum in: Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19132.

7.

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Singh A, Settleman J.

Oncogene. 2010 Aug 26;29(34):4741-51. doi: 10.1038/onc.2010.215. Epub 2010 Jun 7. Review.

8.

Emerging targeted therapies for breast cancer.

Alvarez RH, Valero V, Hortobagyi GN.

J Clin Oncol. 2010 Jul 10;28(20):3366-79. doi: 10.1200/JCO.2009.25.4011. Epub 2010 Jun 7. Review.

PMID:
20530283
10.
11.

Src signaling in cancer invasion.

Guarino M.

J Cell Physiol. 2010 Apr;223(1):14-26. doi: 10.1002/jcp.22011. Review.

PMID:
20049846
12.

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

López-Novoa JM, Nieto MA.

EMBO Mol Med. 2009 Sep;1(6-7):303-14. doi: 10.1002/emmm.200900043. Review.

13.

Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models.

Chang Q, Chen E, Hedley DW.

Cancer Biol Ther. 2009 Oct;8(20):1893-901. Epub 2009 Oct 6.

PMID:
20009539
14.

Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.

Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12903-8. doi: 10.1073/pnas.0810402106. Epub 2009 Jul 17.

15.

The basics of epithelial-mesenchymal transition.

Kalluri R, Weinberg RA.

J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104. Review. Erratum in: J Clin Invest. 2010 May 3;120(5):1786.

16.

Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.

Ma J, DeFrances MC, Zou C, Johnson C, Ferrell R, Zarnegar R.

J Clin Invest. 2009 Mar;119(3):478-91. doi: 10.1172/JCI36640. Epub 2009 Feb 2.

17.

TGF-beta-induced epithelial to mesenchymal transition.

Xu J, Lamouille S, Derynck R.

Cell Res. 2009 Feb;19(2):156-72. doi: 10.1038/cr.2009.5. Review.

18.

SRC-dependent signalling regulates actin ruffle formation induced by glycerophosphoinositol 4-phosphate.

Filippi BM, Mariggiò S, Pulvirenti T, Corda D.

Biochim Biophys Acta. 2008 Dec;1783(12):2311-22. doi: 10.1016/j.bbamcr.2008.07.021. Epub 2008 Aug 3.

19.

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.

Thomson S, Petti F, Sujka-Kwok I, Epstein D, Haley JD.

Clin Exp Metastasis. 2008;25(8):843-54. doi: 10.1007/s10585-008-9200-4. Epub 2008 Aug 12.

PMID:
18696232
20.

KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells.

Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH, Lee JH, Seo YW, Ahn KY, Chung IJ, Kim KK.

Gut. 2009 Apr;58(4):509-19. doi: 10.1136/gut.2008.150938. Epub 2008 Jul 24.

PMID:
18653728
Items per page

Supplemental Content

Write to the Help Desk